Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Fahimeh Ramezani Tehrani, Mina Amiri, Samira Behboudi-Gandevani, Razieh Bidhendi-Yarandi & Enrico Carmina. (2020) Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecological Endocrinology 36:1, pages 12-23.
Read now
Read now
Articles from other publishers (11)
Joanna Majewska, Andrzej Berg, Joanna Jurewicz, Katarzyna Owczarek, Radosław Zajdel, Anna Kilanowicz, Andrzej Wasik & Dominik Rachoń. (2024) Bisphenol A analogues and metabolic syndrome in women with polycystic ovary syndrome. Reproductive Toxicology 123, pages 108511.
Crossref
Crossref
Leander Corrie, Sachin Kumar Singh, Monica Gulati, Ankit Awasthi, Rubiya Khursheed, Jaskiran Kaur & Sukriti Vishwas. (2023) Improvement in Polycystic Ovarian Syndrome using Pharmacological and
Non- Pharmacological Approaches: Current Perspectives and Principles. Current Women s Health Reviews 19:1.
Crossref
Crossref
Dipali Rathod, Rekha Birle, Dr. Nandu Kayande & Dr. Gajanand Engla. (2022) A Review on Pharmacological Non Pharmacological and Herbal Treatment of (PCOS) Polycystic Ovarian Syndrome. International Journal of Advanced Research in Science, Communication and Technology, pages 616-628.
Crossref
Crossref
Joanna Jurewicz, Joanna Majewska, Andrzej Berg, Katarzyna Owczarek, Radosław Zajdel, Dorota Kaleta, Andrzej Wasik & Dominik Rachoń. (2021) Serum bisphenol A analogues in women diagnosed with the polycystic ovary syndrome – is there an association?. Environmental Pollution 272, pages 115962.
Crossref
Crossref
Enrico CarminaRoger A. Lobo. (2018) Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?. Journal of Women's Health 27:11, pages 1385-1388.
Crossref
Crossref
Thakur Rajeev Singh & Sathaiah Sudhamalla. (2018) CUTANEOUS MANIFESTATIONS OF POLYCYSTIC OVARIAN DISEASE. Journal of Evolution of Medical and Dental Sciences 7:26, pages 3053-3057.
Crossref
Crossref
Mina Amiri, Fahimeh Ramezani Tehrani, Fatemeh Nahidi, Ali Kabir, Fereidoun Azizi & Enrico Carmina. (2017) Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins. Metabolism 73, pages 22-35.
Crossref
Crossref
D. M Lukyanova & Tatyana Yu. Smolnova. (2017) THE ROLE OF SYMPATHICOTONIC REACTIVITY OF ORGANISM AND GROWTH FACTORS IN PATHOGENESIS OF SYNDROME OF POLYCYSTIC OVARY. Medical Journal of the Russian Federation 23:2, pages 96-100.
Crossref
Crossref
Ricardo Azziz, Enrico Carmina, ZiJiang Chen, Andrea Dunaif, Joop S. E. Laven, Richard S. Legro, Daria Lizneva, Barbara Natterson-Horowtiz, Helena J. Teede & Bulent O. Yildiz. (2016) Polycystic ovary syndrome. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
V. Bettoli, S. Zauli & A. Virgili. (2015) Is hormonal treatment still an option in acne today?. British Journal of Dermatology 172, pages 37-46.
Crossref
Crossref
Da Eun LeeSoo Yeon ParkSo Yun ParkSa Ra LeeHye Won ChungKyungah Jeong. (2014) Clinical and Biochemical Profiles according to Homeostasis Model Assessment-insulin Resistance (HOMA-IR) in Korean Women with Polycystic Ovary Syndrome. Journal of Menopausal Medicine 20:3, pages 104.
Crossref
Crossref